
SRNE
Healthcare · Biotechnology · $165,384 market cap
$0.00030.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Feb 25, 2026 | Time not confirmed | — | 0.00 | — |
| Nov 28, 2025 | Time not confirmed | — | 0.00 | — |
| Aug 29, 2025 | Time not confirmed | — | 0.00 | — |
| May 30, 2025 | Time not confirmed | — | 0.00 | — |
| Feb 26, 2025 | Time not confirmed | — | -0.17 | — |
| Nov 29, 2024 | Time not confirmed | — | 0.00 | — |
| Aug 13, 2024 | Time not confirmed | — | 0.00 | — |
| May 7, 2024 | Time not confirmed | — | 0.00 | — |
| Feb 28, 2024 | Time not confirmed | -0.09 | 0.00 | +100.0% |
| Nov 3, 2023 | Time not confirmed | -0.15 | 0.00 | +100.0% |
| Aug 14, 2023 | Time not confirmed | -0.15 | -0.17 | -13.3% |
| May 15, 2023 | After the close | -0.16 | -0.26 | -62.5% |
| Mar 9, 2023 | Time not confirmed | -0.23 | -0.23 | 0.0% |
Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, provides therapeutic solutions in the United States and internationally. It offers chimeric antigen receptor T-cell therapy, dimeric antigen receptor T-cell therapy, and antibody-drug conjugates, as well as Seprehvec, SOFUSA, RTX, and SEMDEXA. The company also develops antiviral therapies and vaccines, including Abivertinib,…
| Nov 8, 2022 | After the close | -0.26 | -0.20 | +23.1% |
| Aug 15, 2022 | After the close | -0.20 | -0.54 | -170.0% |
| May 5, 2022 | After the close | -0.22 | -0.12 | +45.5% |
| Mar 11, 2022 | After the close | -0.29 | -0.47 | -62.1% |
| Nov 5, 2021 | After the close | -0.29 | -0.31 | -6.9% |
| Aug 6, 2021 | After the close | -0.24 | -0.35 | -45.8% |
| May 5, 2021 | After the close | -0.15 | 0.05 | +133.3% |
| Feb 19, 2021 | After the close | 2.72 | -0.27 | -109.9% |
| Nov 9, 2020 | Before the open | -0.16 | -0.19 | -18.8% |
| Aug 4, 2020 | After the close | -0.22 | -0.21 | +4.5% |
| May 11, 2020 | After the close | -0.20 | -0.36 | -80.0% |
| Mar 3, 2020 | Before the open | -0.40 | -0.14 | +65.0% |
| Nov 12, 2019 | Before the open | -0.43 | -0.38 | +11.6% |
| Aug 9, 2019 | After the close | -0.40 | -0.35 | +12.5% |
| May 15, 2019 | After the close | -0.31 | -0.15 | +51.6% |
| Mar 15, 2019 | Before the open | -0.27 | -0.41 | -51.9% |
| Nov 9, 2018 | After the close | -0.18 | -0.40 | -122.2% |
| Aug 9, 2018 | After the close | -0.20 | -0.28 | -40.0% |
| May 10, 2018 | After the close | -0.16 | -0.24 | -50.0% |
| Mar 16, 2018 | After the close | -0.14 | 0.58 | +514.3% |